<- Go Home

Inari Medical, Inc.

Inari Medical, Inc. manufactures minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states. The company provides the ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; the FlowTriever system, a large-bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; the InThrill system to treat small vessel thrombosis; and the LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is based in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.

Market Cap

$4.7B

Volume

948.9K

Cash and Equivalents

$41.1M

EBITDA

-$26.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$498.8M

Profit Margin

86.82%

52 Week High

$79.99

52 Week Low

$36.73

Dividend

N/A

Price / Book Value

10.75

Price / Earnings

-59.05

Price / Tangible Book Value

60.21

Enterprise Value

$4.6B

Enterprise Value / EBITDA

-231.96

Operating Income

-$32.0M

Return on Equity

17.72%

Return on Assets

-3.21

Cash and Short Term Investments

$111.5M

Debt

$32.7M

Equity

$434.8M

Revenue

$574.5M

Unlevered FCF

$86.7M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches